Trasylol

Trasylol is a brand name of aprotinin, approved by the FDA in the following formulation(s):

TRASYLOL (aprotinin - injectable; injection)

• 
  Manufacturer: BAYER HLTHCARE
  
  Approval date: December 29, 1993
  
  Strength(s): 10,000KIU/ML ^[RLD]

Has a generic version of Trasylol been approved?

No. There is currently no therapeutically equivalent version of Trasylol available.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Trasylol. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

There are no current U.S. patents associated with Trasylol.

See also...

• Trasylol Consumer Information (Wolters Kluwer)
• Trasylol AHFS DI Monographs (ASHP)
• Aprotinin Consumer Information (Wolters Kluwer)
• Aprotinin AHFS DI Monographs (ASHP)